The condition normally resolves on its own in 2 to 3 weeks, but it might take up to a month.

In many situations, the only therapy required is to alleviate the symptoms, such as lowering a temperature or relieving itching. However, the lesions can become quite severe at times, necessitating strong pain relievers or possibly hospitalization.

Children, pregnant women, and adults with impaired immune systems have had the most severe occurrences. So far, no deaths have been recorded in Europe or the United States. People suffering with monkeypox are advised not to scratch the lesions since this may transmit the virus or create a scar, and to cover them to prevent the urge.

The European Medicines Agency has authorized Tecovirimat, a smallpox drug, for monkeypox therapy. The goal of treatment is to alleviate symptoms. Monkeypox will be moderate for the majority of persons.

Simple pain relievers, such as paracetamol, and staying hydrated are all that is required for someone suffering from monkeypox.

When a person’s symptoms are severe or problems arise, they may require intravenous fluids and additional medications.